Invention Grant
- Patent Title: Triazole derivative
-
Application No.: US11232011Application Date: 2005-09-22
-
Publication No.: US07084164B2Publication Date: 2006-08-01
- Inventor: Takahiko Tobe , Takashi Sugane , Wataru Hamaguchi , Itsuro Shimada , Kyoichi Maeno , Junji Miyata , Tetsuya Kimizuka , Takeshi Suzuki , Atsuyuki Kohara , Takuma Morita , Michael Arlt , Hartmut Greiner
- Applicant: Takahiko Tobe , Takashi Sugane , Wataru Hamaguchi , Itsuro Shimada , Kyoichi Maeno , Junji Miyata , Tetsuya Kimizuka , Takeshi Suzuki , Atsuyuki Kohara , Takuma Morita , Michael Arlt , Hartmut Greiner
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma, Inc.
- Current Assignee: Astellas Pharma, Inc.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JPP.2000-148419 20000519; JPP.2001-47921 20010223
- Main IPC: A61K31/41
- IPC: A61K31/41 ; C07D249/08

Abstract:
The invention relates to a triazole derivative with an activity inhibiting glycine transporter and for use as a pharmaceutical drug, and a novel triazole derivative. The inventive triazole derivative has an excellent activity inhibiting glycine transporter and is useful as a therapeutic agent of dementia, schizophrenia, cognitive disorders, or cognitive disorders involved in various diseases such as Alzheimer disease, Parkinson's disease, or Huntington disease or the like, or spasm involved in diseases such as nerve degenerative diseases and cerebrovascular disorders, or the like. Particularly, the pharmaceutical drug is useful for the amelioration of learning disability of dementia and the like.
Public/Granted literature
- US20060025461A1 Triazole derivative Public/Granted day:2006-02-02
Information query